Clinical Trial: A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07604116) titled 'A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA' on May 17.

Brief Summary: The non-randomized, open-label phase I study aims to evaluate the safety, tolerability, biodistribution, radiation dosimetry, and pharmacokinetics of SST001 in healthy volunteers, patients with MSA and patients with PD.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Multiple System Atrophy (MSA) Parkinson's Disease (PD)

Intervention: DRUG: SST001

Participants will undergo PET imaging after administration.

Recr...